Prevalence of chronic obstructive pulmonary disease in Fez, Morocco

Results from the BOLD study

K. El Rhazi, C. Nejjari, M. C. Ben Jelloun, M. El Biaze, M. Attassi, Vanessa Garcia-Larsen    

Research output: Contribution to journalArticle

Abstract

Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6%. The prevalence of GOLD stage 2 or higher COPD was 7.9%. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8% among non-smokers, and it increased with number of pack-years (17.8% for.20 pack-years vs. 3.8% for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2%; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.

Original languageEnglish (US)
Pages (from-to)136-141
Number of pages6
JournalInternational Journal of Tuberculosis and Lung Disease
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Morocco
Chronic Obstructive Pulmonary Disease
Lung Diseases
Bronchodilator Agents
Spirometry
Smoking
Population
Health Status
Quality of Life
Guidelines
Physicians

Keywords

  • BOLD study
  • COPD prevalence
  • Morocco CHRONIC OBSTRUCTIVE pulmonary disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Prevalence of chronic obstructive pulmonary disease in Fez, Morocco : Results from the BOLD study. / El Rhazi, K.; Nejjari, C.; Ben Jelloun, M. C.; El Biaze, M.; Attassi, M.; Garcia-Larsen    , Vanessa.

In: International Journal of Tuberculosis and Lung Disease, Vol. 20, No. 1, 01.01.2016, p. 136-141.

Research output: Contribution to journalArticle

El Rhazi, K. ; Nejjari, C. ; Ben Jelloun, M. C. ; El Biaze, M. ; Attassi, M. ; Garcia-Larsen    , Vanessa. / Prevalence of chronic obstructive pulmonary disease in Fez, Morocco : Results from the BOLD study. In: International Journal of Tuberculosis and Lung Disease. 2016 ; Vol. 20, No. 1. pp. 136-141.
@article{128efd4b254741a396d5330da12db5a1,
title = "Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: Results from the BOLD study",
abstract = "Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6{\%}. The prevalence of GOLD stage 2 or higher COPD was 7.9{\%}. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8{\%} among non-smokers, and it increased with number of pack-years (17.8{\%} for.20 pack-years vs. 3.8{\%} for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2{\%}; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.",
keywords = "BOLD study, COPD prevalence, Morocco CHRONIC OBSTRUCTIVE pulmonary disease",
author = "{El Rhazi}, K. and C. Nejjari and {Ben Jelloun}, {M. C.} and {El Biaze}, M. and M. Attassi and {Garcia-Larsen    }, Vanessa",
year = "2016",
month = "1",
day = "1",
doi = "10.5588/ijtld.15.0029",
language = "English (US)",
volume = "20",
pages = "136--141",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "1",

}

TY - JOUR

T1 - Prevalence of chronic obstructive pulmonary disease in Fez, Morocco

T2 - Results from the BOLD study

AU - El Rhazi, K.

AU - Nejjari, C.

AU - Ben Jelloun, M. C.

AU - El Biaze, M.

AU - Attassi, M.

AU - Garcia-Larsen    , Vanessa

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6%. The prevalence of GOLD stage 2 or higher COPD was 7.9%. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8% among non-smokers, and it increased with number of pack-years (17.8% for.20 pack-years vs. 3.8% for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2%; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.

AB - Objective: To present population-estimated prevalence of spirometrically confirmed chronic obstructive pulmonary disease (COPD) in adults (age 740 years), living in the city of Fez, Morocco. D E S IGN: Following the Burden of Lung Disease (BOLD) methodology, population-based sampling plans were used for the recruitment of eligible adults. The study collected questionnaire data on respiratory symptoms, medical history, health status, exposure to risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed and COPD and its stages were defined according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Results: Among 768 individuals with valid data and acceptable quality post-bronchodilator spirometry results, the overall prevalence of stage 1 or higher COPD was 12.6%. The prevalence of GOLD stage 2 or higher COPD was 7.9%. The population-estimated prevalence of lower limit of normal (LLN) modified stage 1 or higher COPD was 8% among non-smokers, and it increased with number of pack-years (17.8% for.20 pack-years vs. 3.8% for,10 pack-years). The prevalence of physician-diagnosed COPD was 3.2%; this was associated with an increase in smoking pack-years. Conclusion: These results emphasise the urgent need to take necessary measures to reduce the prevalence of tobacco smoking.

KW - BOLD study

KW - COPD prevalence

KW - Morocco CHRONIC OBSTRUCTIVE pulmonary disease

UR - http://www.scopus.com/inward/record.url?scp=84951997433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951997433&partnerID=8YFLogxK

U2 - 10.5588/ijtld.15.0029

DO - 10.5588/ijtld.15.0029

M3 - Article

VL - 20

SP - 136

EP - 141

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 1

ER -